Mélanie Wilbaux
-
- Pharmaceutical studies and practices 5
- Statistics and Probability top 5%
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Ovarian cancer diagnosis and treatment 3
-
- Cancer Genomics and Diagnostics 5
-
- Cancer Cells and Metastasis 3
-
- Prostate Cancer Treatment and Research 3
-
- Fibroblast Growth Factor Research 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Marc PfisterJohannes N. van den AnkerFrédérique RodieuxBenoît YouMichel TodGilles FreyerÉmilie HéninSven Wellmann
- Journals
- Journal of Clinical Oncology (3 papers)British Journal of Cancer (2 papers)Annals of Oncology (1 paper)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Mélanie Wilbaux
21 papers receiving 408 citations
Peers
Comparison fields: 5 of 92
- Pediatrics, Perinatology and Child Health 156
- Statistics and Probability 53
- Pharmacology 109
- Applied Microbiology and Biotechnology 12
- Reproductive Medicine 34
Countries citing papers authored by Mélanie Wilbaux
This map shows the geographic impact of Mélanie Wilbaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Wilbaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Wilbaux more than expected).
Fields of papers citing papers by Mélanie Wilbaux
This network shows the impact of papers produced by Mélanie Wilbaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Wilbaux. The network helps show where Mélanie Wilbaux may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mélanie Wilbaux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2022 | 6 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 8 | |
| 5 | 2020 | 47 | |
| 6 | 2019 | 2 | |
| 7 | 2018 | 13 | |
| 8 | 2016 | 12 | |
| 9 | 2016 | 16 | |
| 10 | 2016 | 3 | |
| 11 | 2016 | 5 | |
| 12 | 2016 | 61 | |
| 13 | 2015 | 96 | |
| 14 | 2015 | 2 | |
| 15 | 2015 | 22 | |
| 16 | 2014 | 20 | |
| 17 | 2014 | 23 | |
| 18 | 2013 | 32 | |
| 19 | 2013 | 36 | |
| 20 | 2013 | 1 |
About Mélanie Wilbaux
Mélanie Wilbaux is a scholar working on Pediatrics, Perinatology and Child Health, Reproductive Medicine and Cancer Research, having authored 21 papers that have together received 414 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Pharmaceutical studies and practices (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer Cells and Metastasis (3 papers), Prostate Cancer Treatment and Research (3 papers), Fibroblast Growth Factor Research (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (156 citations), Statistics and Probability (53 citations) and Pharmacology (109 citations). Mélanie Wilbaux has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Marc Pfister, Johannes N. van den Anker, Frédérique Rodieux, Benoît You, Michel Tod, Gilles Freyer, Émilie Hénin, Sven Wellmann, Janko Samardžić and Karel Allegaert. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.